Strides Arcolab stock up on US FDA nod

Shares in Strides Arcolab Ltd rose by 5% after company received US FDA approval for Gemcitabine injection.

• Written by Agencies
• Mumbai | July 26, 2011 11:08 AM IST
1 min read

Shares in Strides Arcolab Ltd rose more than 5 per cent after the company said it has received US FDA approval for generic version of Gemcitabine injection used in the treatment of cancer,dealers said. At about 10 am shares were up 3.81 per cent to 381.55 rupees in a flat Mumbai market.

Company INFO

You’ve Read Your Free Stories For Now

Sign up and keep reading more stories that matter to you.

Create Free Account

Already have an account? Sign In

This story requires a subscription

Select a plan and use IE10 code to get 10% extra off

POPULAR

EXPRESS EDGE

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹117/month

Best for news lovers

UPSC PACK

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹133/month

Best for UPSC aspirants

Already a subscriber? Sign in

This premium article is free for now.

Register to continue reading this story

Free Read

Already have an account? Sign In

This story requires a subscription

Please Select A Plan

POPULAR

EXPRESS EDGE

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹117/month

Best for news lovers

UPSC PACK

Daily ePaper access

Premium stories & archives

UPSC Section + UPSC Essentials Magazine

Starts at ₹133/month

Best for UPSC aspirants

This content is exclusive for our subscribers.

Subscribe now to get unlimited access to The Indian Express exclusive and premium stories.

Continue

Already a subscriber? Sign In